PROBIODRUG
DEAD

Serial Number

76471856

Owner

Probiodrug AG

Attorney

DAVID TOREN

Filing Date

Nov 20, 2002

Add to watchlist:

No watchlists yet
View on USPTO

PROBIODRUG Trademark

Serial Number: 76471856 • Registration: 2833852

PROBIODRUG is a trademark filed by Probiodrug AG on November 20, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Probiodrug AG

Weinbergweg 22
06120 Halle , DE

Entity Type: 03

Trademark Details

Filing Date

November 20, 2002

Registration Date

April 20, 2004

Published for Opposition

January 27, 2004

Cancellation Date

November 26, 2010

Goods & Services

educational services, namely conducting classes, seminars, conferences and workshops in the field of human medicine, veterinary medicine, human nutrition, pet nutrition and agriculture

Pharmaceutical preparations for the treatment of non-insulin dependent diabetes mellitus (type 2), impaired glucose tolerance, glucosuria, and disturbances of signal action at the cells of the islets of Langerhans and insulin sensitivity in the peripheral tissue in the postprandial phase of mammals, insulin resistance, metabolic acidosis, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus, diabetes mellitus type 1, lipid disorders, hyperlipidemia, metabolism-related hypertension and cardiovascular sequelae caused by hypertension in mammals; pharmaceutical preparations for the treatment of atherosclerosis and its sequelae, inflammatory bowel disease, namely, Crohn's disease and ulcerative colitis, pancreatitis, tumor metastasis, benign prostatic hypertrophy, gingivitis, osteoporosis; pharmaceutical preparations for the prophylaxis or treatment of skin diseases and diseases of the mucosae, autoimmune diseases and inflammatory conditions, and for the prophylaxis or treatment of psychosomatic, neuropsychiatric and depressive illness, and neurodegenerative diseases namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, nutritional disorders, spasm, and chronic pain, multiple sclerosis, Alzheimer's disease; Veterinary preparations for the treatment of metabolic diseases, cancerous diseases, psychosomatic, neuropsychiatric, depressive and neurodegenerative diseases in livestock and domestic animals; All purpose disinfectants, diagnostic reagents for clinical or medical use; Dietary supplements, food for enteral feeding; Agrochemicals, namely fungicides, herbicides and insecticides for agricultural and domestic use

Chemical preparations for the use in the manufacture of pharmaceuticals for the treatment of type 2 diabetes, impaired glucose tolerance, glucosuria, and disturbances of signal action at the cells of the islets of Langerhans and insulin sensitivity in the peripheral tissue in the postprandial phase of mammals, insulin resistance, metabolic acidosis, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus, diabetes mellitus type 1, lipid disorders, hyperlipidemia, metabolism-related hypertension and cardiovascular sequelae caused by hypertension in mammals, atherosclerosis and its sequelae, inflammatory bowel disease, namely, Crohn's disease and ulcerative colitis, pancreatitis, tumor metastasis, benign prostatic hypertrophy, gingivitis, osteoporosis, for the prophylaxis or treatment of skin diseases and diseases of the mucosae, autoimmune diseases and inflammatory conditions, and for the prophylaxis or treatment of psychosomatic, neuropsychiatric and depressive illness, and neurodegenerative diseases namely anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, nutritional disorders, spasm, and chronic pain, multiple sclerosis, Alzheimer's disease, Down Syndrome, and for use in the manufacture of contraceptive drugs for scientific, medical and biological purposes, diagnostic preparations and reagents for use in scientific and medical research

surgical, medical, dental and veterinary instruments and apparatus, namely electronic monitors, recorders and analyzers for blood pressure, blood analysis, blood glucose, insulin in the blood, pH Monitors

Chemist, physicist, microbiologist, biologist and Chemical, biological and medical research in the field of drugs and genetic engineering

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 26, 2010 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2006 TCCA
REGISTERED-PRINCIPAL REGISTER
Apr 20, 2004 R.PR
PUBLISHED FOR OPPOSITION
Jan 27, 2004 PUBO
NOTICE OF PUBLICATION
Jan 7, 2004 NPUB
Sec. 1(B) CLAIM DELETED
Nov 25, 2003 1.BD
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2003 TROA
PAPER RECEIVED
Nov 13, 2003 MAIL
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2003 CNSA
EXAMINERS AMENDMENT MAILED
Oct 23, 2003 CNEA
CASE FILE IN TICRS
Jul 2, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2003 CRFA
PAPER RECEIVED
Jun 16, 2003 MAIL
NON-FINAL ACTION MAILED
Mar 24, 2003 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2003 DOCK
PAPER RECEIVED
Jan 31, 2003 MAIL